This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Jun 1;33(6):439-41.

doi: 10.2165/11532400-000000000-00000.

Placebo harm

I Ralph Edwards, Joe Graedon, Terry Graedon

PMID: 20486726
DOI: 10.2165/11532400-000000000-00000

Editorial

Placebo harm

I Ralph Edwards et al. Drug Saf. 2010.

. 2010 Jun 1;33(6):439-41.

doi: 10.2165/11532400-000000000-00000.

Authors

I Ralph Edwards, Joe Graedon, Terry Graedon

PMID: 20486726
DOI: 10.2165/11532400-000000000-00000

No abstract available

PubMed Disclaimer

Comment on

Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis.
Rief W, Nestoriuc Y, von Lilienfeld-Toal A, Dogan I, Schreiber F, Hofmann SG, Barsky AJ, Avorn J. Rief W, et al. Drug Saf. 2009;32(11):1041-56. doi: 10.2165/11316580-000000000-00000. Drug Saf. 2009. PMID: 19810776

References

1. Med World. 1961 Sep;95:203-5 - PubMed
1. Psychosom Med. 2006 May-Jun;68(3):478-86 - PubMed
1. Drug Saf. 2009;32(11):1041-56 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer